Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.49 |
| ▸ | ERCC1 | P07992 | 2/20 | 0.47 |
| ▸ | FEN1 | P39748 | 2/20 | 0.47 |
| ▸ | ERCC4 | Q92889 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.42 |
| ▸ | WDR5 | P61964 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL567138 | 0.98 | DNMT1 (0.50) | DNMT1ERCC1FEN1ERCC4POLB | |
| SCHEMBL65123 | 0.85 | TSHR (0.44) | DNMT1ERCC1FEN1ERCC4POLB | |
| Trifluoromethanesulfonic Acid SCHEMBL51718 | 0.85 | DNMT1 (0.43) | DNMT1ERCC1FEN1ERCC4POLB | |
| SCHEMBL3144814 | 0.81 | ALDH1A1 (0.48) | DNMT1MAPTCYP1A2TDP1KMT2A | |
| SCHEMBL6734024 | 0.76 | DNMT1 (0.50) | DNMT1POLBMAPTCYP1A2ALOX12 | |
| SCHEMBL4104478 | 0.76 | DNMT1 (0.50) | DNMT1POLBMAPTCYP1A2ALOX12 | |
| SCHEMBL4109839 | 0.76 | DNMT1 (0.50) | DNMT1POLBMAPTCYP1A2ALOX12 | |
| SCHEMBL8407062 | 0.76 | DNMT1 (0.50) | DNMT1POLBMAPTCYP1A2ALOX12 | |
| SCHEMBL10426593 | 0.76 | DNMT1 (0.50) | DNMT1POLBMAPTCYP1A2ALOX12 | |
| SCHEMBL11877346 | 0.76 | DNMT1 (0.46) | DNMT1POLBMAPTCYP1A2ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11213804-B2 | Dehydrogenation catalysts and methods of making and using the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-01-04 | — | — | US | disclosed |
| EP-3327003-B1 | PROCESS FOR CONCENTRATING A MIXTURE CONTAINING ORGANIC HYDROPEROXIDE | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-09-16 | — | — | EP | disclosed |
| CN-106716252-B | Photosensitive resin composition, cured film and method for producing same, liquid crystal display device, organic electroluminescence display device, and touch panel | 富士胶片株式会社 | 2020-01-07 | — | — | CN | disclosed |
| CN-106687865-B | TFT substrate, organic EL display device, and method for manufacturing liquid crystal display device | 富士胶片株式会社 | 2020-01-03 | — | — | CN | disclosed |
| EP-3180304-B1 | PROCESS FOR PRODUCING CYCLOHEXANONE | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-10-30 | — | — | EP | disclosed |
| US-20190283002-A1 | Dehydrogenation Catalysts and Methods of Making and Using the Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-09-19 | — | — | US | disclosed |
| EP-3013779-B1 | PROCESS FOR PRODUCING PHENOL AND/OR CYCLOHEXANONE | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-07-31 | — | — | EP | disclosed |
| EP-3013795-B1 | PROCESS FOR CONCENTRATING A MIXTURE CONTAINING ORGANIC HYDROPEROXIDE | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2019-07-24 | — | — | EP | disclosed |
| US-10351506-B2 | Purified plasticizers, production and use | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20190176131-A1 | Methods of Making Supported Mixed Metal Dehydrogenation Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-06-13 | — | — | US | disclosed |
| US-6348475-B1 | POLYMERASE INHIBITOR | GUILFORD PHARMACEUTICALS INC. | 2002-02-19 | — | — | US | disclosed |
| US-20020019417-A1 | Methods, compounds and compositions for treating gout | EISAI INC. | 2002-02-14 | — | — | US | disclosed |
| WO-2001091796-A2 | METHODS, COMPOUNDS AND COMPOSITIONS FOR TREATING GOUT | GUILFORD PHARMACEUTICALS INC. (US) | 2001-12-06 | — | — | WO | disclosed |
| US-6297403-B1 | OXIDATION OF A (DI)ARYL METHANE OR METHYLENE DERIVATIVE IN PRESENCE OF AN AMINE OXIDE OR HYDROXYAMINE DERIVATIVE MEDIATOR; BY-PRODUCT INHIBITION | Consortium für elektrochemische Industrie GmbH (DE) | 2001-10-02 | — | — | US | disclosed |
| US-6242245-B1 | DELIGNIFICATION BY ADDING SUSPENSION OF LACCASE, OXIDANT, MEDIATOR SUCH AS VIOLURIC ACID, AND XYLANASE TO AQUEOUS SUSPENSION OF LIGNIN MATERIAL AND MIXING; MEDIATOR DOES NOT DEACTIVATE ENZYME | Consortium für elektrochemische Industrie GmbH (DE) | 2001-06-05 | — | — | US | disclosed |
| US-6187170-B1 | SYSTEM FOR THE ELECTROCHEMICAL CLEAVAGE OF COMPOUNDS WHICH INCLUDES A MEDIATOR AND AT LEAST TWO ELECTRODES FOR THE ELECTROCHEMICAL ACTIVATION OF THE MEDIATOR | Consortium für elektrochemische Industrie GmbH (DE) | 2001-02-13 | — | — | US | disclosed |
| US-6169213-B1 | REACTING A HETEROARYL METHANOL WITH AN OXIDANT AND A MEDIATOR CONTAINING AMINO OXIDE GROUP TO FORM HETEROARYL ALDEHYDE OR A HETEROARYL KETONE | Consortium f{umlaut over (u)}r elektrochemische Industrie GmbH (DE) | 2001-01-02 | — | — | US | disclosed |
| US-6069282-A | REACTION OF VINYL-, ALKYNYL- OR ARYL-METHANOLS WITH THE AID OF A MEDIATOR AND AN OXIDANT, WHEREIN THE MEDIATOR IS SELECTED FROM THE GROUP OF THE ALIPHATIC, CYCLOALIPHATIC, HETEROCYCLIC OR AROMATIC NO OR NOH CONTAINING COMPOUNDS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2000-05-30 | — | — | US | disclosed |
| US-6023000-A | Process for the preparation of aldehydes and ketones | Consortium fur elektrochemisch Industrie GmbH (DE) | 2000-02-08 | — | — | US | disclosed |
| WO-1999008680-A1 | METHOD OF USING SELECTIVE PARP INHIBITORS TO PREVENT OR TREAT NEUROTOXICITY | THE JOHNS HOPKINS UNIVERSITY (US) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11213804-B2 | Dehydrogenation catalysts and methods of making and using the same | IDH2, ADH4, IDH1 | DNMT1 51/4885ERCC1 1492/4885FEN1 448/4885 |
| US-10351506-B2 | Purified plasticizers, production and use | ALKBH3, FTO, ALK | DNMT1 363/4885ERCC1 625/4885FEN1 494/4885 |
| US-20190176131-A1 | Methods of Making Supported Mixed Metal Dehydrogenation Catalysts | SOD1, DNMT1, CA1 | DNMT1 2/4885ERCC1 1224/4885FEN1 389/4885 |
| US-20020019417-A1 | Methods, compounds and compositions for treating gout | PARP2, PARP1, PARP3 | DNMT1 1772/4885ERCC1 139/4885FEN1 201/4885 |
| US-20190283002-A1 | Dehydrogenation Catalysts and Methods of Making and Using the Same | IDH2, ADH4, IDH1 | DNMT1 51/4885ERCC1 1492/4885FEN1 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.